Page 205 - Critical Care Notes
P. 205

4223_Tab07_199-215  03/09/14  4:25 PM  Page 199





                                199
             Hematological and Oncological Disorders
               Disseminated Intravascular Coagulation (DIC)
          DIC is a disorder characterized by massive systemic intravascular activation of
          the coagulation cascade caused by a variety of clinical conditions, including
          sepsis (gram-positive and gram-negative infections), severe trauma or burns,
          solid or hematological cancers, organ destruction (i.e., pancreatitis), severe
          transfusion reactions, and vascular abnormalities. It can also be caused by
          some obstetrical conditions, such as placental abruption, amniotic fluid
          embolism, placenta previa, and retained dead fetus syndrome.
          Pathophysiology
          ■ Activation of thrombus → fibrinogen fibrin formation and deposition of
            fibrin in the microvasculature → an ↑ in platelet aggregation or adhesions →
            formation of fibrin clots to form → diffuse obstruction of the smaller
            vessels → progressive organ dysfunction (i.e., renal insufficiency, ARDS,
            hypotension, circulatory failure, skin necrosis).
          ■ Concurrent with these events, platelets, prothrombin, and fibrinogen are
            depleted → a deficiency of these factors compromising coagulation and
            predisposing to bleeding.
          ■ The excessive clotting at the microvasculature level activates the fibrinolytic
            system → production of fibrin degradation products (FDPs) (i.e., fibrin split
            products) → an anticoagulation effect of FDP with fibrinogen and thrombin →
            interference with the formation of fibrin clot and decreased platelet function →
            bleeding → hemorrhagic bleeding.
          Clinical Presentation
          ■ Bleeding (purpura, petechiae, ecchymosis)
          ■ GI bleeding (hematemesis, melena, tarry stools)
          ■ GU/GYN bleeding (hematuria, menorrhagia in women) and oliguria
          ■ Wound bleeding
          ■ Bleeding and oozing from puncture sites and around invasive catheters
            and lines
          ■ Hematoma formation
          ■ Dyspnea
          ■ Pulmonary hemorrhage and hypoxia
          ■ Large foci of skin necrosis (resulting from tissue injury and necrosis
            associated with compromised circulation)
          ■ Acrocyanosis (cyanosis of hands and feet)
          ■ Acute multiorgan dysfunction (characterized by hypotension, tachycardia,
            oliguria, dyspnea, confusion, convulsions, coma, abdominal pain, diarrhea,
            and other GI symptoms)
                                             HEMA/
                                             ONCO
   200   201   202   203   204   205   206   207   208   209   210